Drugs / Leucovorin L
Leucovorin L
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT01858662 Comparator | Jan 2014 → Nov 2015 | colorectal cancer | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Terminated | No outcome recorded |
| Phase 2 | NCT01858649 Comparator | May 2013 → May 2019 | colorectal cancer | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Completed | No outcome recorded |
| Phase 3 | NCT01895257 Comparator | Aug 2013 → Dec 2017 | colorectal cancer | University of Antwerp | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leucovorin L | “Day 1 Hour 0: Leucovorin L (levoleucovorin) 200 mg/m2 (or folinic acid 400 mg/m²) in 250 ml glucose 5%, 2-hour IV infusion” NCT01895257 ↗2“Leucovorin L (levoleucovorin) 200 mg/m2 (or folinic acid 400 mg/m²) in 250 ml glucose 5%, IV infusion 3 to 6 cycles” NCT01858649 ↗ |
| Known as | folinic acid | “Day 1 Hour 0: Leucovorin L (levoleucovorin) 200 mg/m2 (or folinic acid 400 mg/m²) in 250 ml glucose 5%, 2-hour IV infusion” NCT01895257 ↗1“Leucovorin L (levoleucovorin) 200 mg/m2 (or folinic acid 400 mg/m²) in 250 ml glucose 5%, IV infusion 3 to 6 cycles” NCT01858649 ↗ |
| Known as | levoleucovorin | “Leucovorin L (levoleucovorin) 200 mg/m2 (or folinic acid 400 mg/m²) in 250 ml glucose 5%, IV infusion 3 to 6 cycles” NCT01858649 ↗ |
| Route | Intravenous | “IV infusion 3 to 6 cycles” NCT01858649 ↗ |